Toward Future Radiotherapy: Beams Characterization through Physical and Radiobiological Modeling

A special issue of Radiation (ISSN 2673-592X).

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 405

Special Issue Editors


E-Mail Website
Guest Editor
1. Institute of Molecular Bioimaging and Physiology (IBFM-CNR), 90015 Cefalù, Italy
2. National Laboratory of South, National Institute for Nuclear Physics (LNS-INFN), 95123 Catania, Italy
Interests: radiobiology; ionizing radiation; immunology; omics; cancer; radiotherapy; particle therapy; radiogenomics

E-Mail
Guest Editor
1. Institute of Molecular Bioimaging and Physiology (IBFM-CNR), 90015 Cefalù, Italy
2. National Laboratory of South, National Institute for Nuclear Physics (LNS-INFN), 95123 Catania, Italy
Interests: radiobiology; ionizing radiation; omics; cancer; radiotherapy; particle therapy, radiogenomics

Special Issue Information

Dear Colleagues,

Particle therapy, using protons or heavier ions, is an innovative type of radiation treatment (RT) that opens up new possibilities for cancer treatment, thanks to the possibility of delivering the maximum dose to the tumor along the so-called Bragg peak, minimizing damage to surrounding normal tissues. In addition, “FLASH” radiotherapy is another promising innovation due to the interesting effect observed, i.e., normal tissue being spared when treatments are delivered with larger dose rates (100 times or more) with respect to the conventional ones.

In this scenario, moving from the bench to the bedside in radiobiology studies is complicated and requires feasibility evaluations, as well as dosimetric and irradiation setups, changing and adapting every time to the beam type used, thus generating variability among the results obtained worldwide. Indeed, the beam quality or dimension often requires specific sample support adaptation and appropriate radiobiological model selection (i.e., the cell type and quantity, irradiation mode of preclinical models, etc.). Furthermore, choosing the correct radiobiological models strongly affects the possibility to obtain information on gene and protein expression, omics biomarkers, the percent of cancer stem cells, and the activation of the bystander effect or hypoxia, which are also strongly related to radiation regimens and dosage.

Aim. This Special Issue will give the readers an insight into worldwide research on these topics and will try to highlight the most effective radiobiological models used in every specific irradiation condition for several beam types.

Proposed Letter

To date, radiobiology research has required feasibility assessments as well as the adaption of dosimetric and irradiation settings to appropriate in vitro or in vivo models, based on the type of beam used. Thus, these steps are crucial in order to obtain accurate results in terms of survival and molecular response to the innovative treatments using particle beams and FLASH radiotherapy.

We are pleased to invite you to contribute to this Special Issue which will give the readers an insight into the worldwide research on these topics and will try to highlight the most effective radiobiological models and settings, used in every specific irradiation condition for several types of the beam. We encourage scientists to deeply describe their cellular and molecular results obtained in each specific irradiation condition.

In this Special Issue, original research articles and reviews are welcome regarding the following research areas:

  • Particle therapy studies through physical and radiobiological models.
  • FLASH radiotherapy studies through physical and radiobiological models.
  • Radiation detection, dosimetry and Monte Carlo simulations applied to radiobiological studies.
  • Use of different radiobiological in vitro models: immortalized; primary and genetically engineered cells.
  • Use of different radiobiological in vivo models: from Zebrafish to mammals.
  • Radiobiological models for personalized radiation therapy.

 We look forward to receiving your contributions.

Dr. Giusi Irma Forte
Dr. Valentina Bravatà
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Radiation is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • particle therapy
  • FLASH radiotherapy
  • radiobiological models
  • in vitro and preclinical studies
  • omics sciences
  • radiation detection, modelling, dosimetry and Monte Carlo simulations applied to radiobiological studies

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop